Robinson M T, Schumaker V N, Butler R, Berg K, Curtiss L K
Arteriosclerosis. 1986 May-Jun;6(3):341-4. doi: 10.1161/01.atv.6.3.341.
A monoclonal antibody directed against human apolipoprotein B, which was previously shown in family studies to detect allelic variations (J Biol Chem 1984; 259:6423-6430), has now been identified with the Ag(c) factor. This identification allows the location of the Ag system on the structural gene for apolipoprotein B and on the short arm of human chromosome 2. The epitope corresponding to Ag(c) is located within the amino acid sequence common to apolipoproteins B-100 and B-48. Since a single molecule of apolipoprotein B-100 is present on human LDL, individual LDL possesses either the epitope corresponding to Ag(c) or that corresponding to Ag(g). These studies on allelic variation among human apolipoprotein B species parallel similar studies in animals in which a relationship to atherosclerosis was found.
一种针对人载脂蛋白B的单克隆抗体,先前在家族研究中已显示可检测等位基因变异(《生物化学杂志》1984年;259:6423 - 6430),现在已被确定与Ag(c)因子相关。这一确定使得Ag系统能够定位在载脂蛋白B的结构基因以及人类第2号染色体的短臂上。对应于Ag(c)的表位位于载脂蛋白B - 100和B - 48共有的氨基酸序列内。由于人低密度脂蛋白(LDL)上存在单个载脂蛋白B - 100分子,个体LDL要么具有对应于Ag(c)的表位,要么具有对应于Ag(g)的表位。这些关于人类载脂蛋白B物种中等位基因变异的研究与在动物中发现与动脉粥样硬化有关的类似研究相似。